Government of Northern Ireland

Aviceda Therapeutics Announces Additional World-Class Members to its Scientific Advisory Board

Retrieved on: 
Monday, September 20, 2021

Aviceda Therapeutics, an IND-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing additional members of its Scientific Advisory Board who will help shape ongoing research and development efforts.

Key Points: 
  • Aviceda Therapeutics, an IND-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing additional members of its Scientific Advisory Board who will help shape ongoing research and development efforts.
  • The new additional Aviceda Scientific Advisory Board members includes:
    Aviceda is honored and privileged to add new world-class scientists and renowned researchers to join our efforts in developing the next generation of glyco-immune therapeutics for the treatment of immune-dysfunction conditions, said Mohamed A. Genead, MD, Co-Founder & President of Aviceda Therapeutics.
  • She published more than 280 scientific papers in well recognized journals (Cell, Nature, Nature Immunology, PNAS, and JEM) and supervised 29 PhD students.
  • The Aviceda team is already building on the foundational work in the emerging field of glycobiology to develop potential therapeutics and interventional strategies.

Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer

Retrieved on: 
Tuesday, June 1, 2021

will be joining Onconova as Chief Medical Officer (CMO), effective as of June 14, 2021.

Key Points: 
  • will be joining Onconova as Chief Medical Officer (CMO), effective as of June 14, 2021.
  • He will add great depth to our management team, said Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova.
  • I am thrilled that Mark will be joining Onconova and eager to begin working together.
  • Dr. Gelder is an accomplished industry leader with more than 35 years of experience in clinical development, medical affairs, and medical marketing.

Police Service of Northern Ireland Chooses Box for Cloud Content Management

Retrieved on: 
Thursday, April 22, 2021

b'Box, Inc. (NYSE:BOX), the leading Content Cloud, today announced that the Police Service of Northern Ireland has expanded its relationship with Box.

Key Points: 
  • b'Box, Inc. (NYSE:BOX), the leading Content Cloud, today announced that the Police Service of Northern Ireland has expanded its relationship with Box.
  • Headquartered in Belfast, the Police Service of Northern Ireland is using Box as its secure, integrated platform to power Digital Policing and serve Northern Ireland\xe2\x80\x99s 1.8 million residents.\n\xe2\x80\x9cAt the Police Service of Northern Ireland, our mission is to keep people safe in the digital age, and exceptional technology services and solutions are central to accomplishing that,\xe2\x80\x9d said Jeff McNamara, Head of Information and Communication Services at the Police Service of Northern Ireland.
  • \xe2\x80\x9cThanks to Box we\xe2\x80\x99re able to focus on providing more effective policing for the benefit of the community.\xe2\x80\x9d\n\xe2\x80\x9cThe Police Service of Northern Ireland is a leading service that is highly focused on transforming policing through digital innovation,\xe2\x80\x9d said Stephanie Carullo, COO of Box.
  • \xe2\x80\x9cWe\xe2\x80\x99re excited that Box can play a central role in helping to power the vital work of public service and protection across Northern Ireland.\xe2\x80\x9d\nThe Police Service of Northern Ireland first became a Box customer in 2018.

Doc Patels' Appoints Dakota Sullivan Chief Executive Officer and Names Dr. Rachna Patel as Chief Medical Officer

Retrieved on: 
Tuesday, September 15, 2020

OAK BROOK, Ill., Sep 15, 2020 /PRNewswire/ --Doc Patels' LLC, a leading provider of organic, broad-spectrum CBD products, today announced that Dakota Sullivan has been appointed chief executive officer.

Key Points: 
  • OAK BROOK, Ill., Sep 15, 2020 /PRNewswire/ --Doc Patels' LLC, a leading provider of organic, broad-spectrum CBD products, today announced that Dakota Sullivan has been appointed chief executive officer.
  • Dr. Rachna Patel, currently chief executive officer, has been appointed to the newly created position of chief medical officer.
  • Prior to joining Doc Patels', Sullivan was co-founder, CEO of Calyx Brands, Inc, a wholesale distributor of THC and CBD products.
  • With the appointment, Dr. Rachna Patel will be stepping into the new role of chief medical officer.

Northern Ireland minister Robin Walker MP questioned on the Protocol on Ireland/Northern Ireland

Retrieved on: 
Friday, July 24, 2020

The House of Lords EU Committee takes evidence from Robin Walker MP, Minister of State, Northern Ireland Office on the measures being taken by the Northern Ireland Office to prepare for the implementation of the Protocol on Ireland/Northern Ireland.

Key Points: 
  • The House of Lords EU Committee takes evidence from Robin Walker MP, Minister of State, Northern Ireland Office on the measures being taken by the Northern Ireland Office to prepare for the implementation of the Protocol on Ireland/Northern Ireland.
  • Northern Ireland Office engagement with other Government departments, the Northern Ireland Executive, the political parties of Northern Ireland, and the Irish Government in relation to the Protocol
    The Northern Ireland Office's responsibility for engagement with Northern Ireland businesses, and how their concerns over implementation of the Protocol are being addressed

Northern Ireland minister Robin Walker MP questioned on the Protocol on Ireland/Northern Ireland

Retrieved on: 
Friday, July 24, 2020

The House of Lords EU Committee takes evidence from Robin Walker MP, Minister of State, Northern Ireland Office on the measures being taken by the Northern Ireland Office to prepare for the implementation of the Protocol on Ireland/Northern Ireland.

Key Points: 
  • The House of Lords EU Committee takes evidence from Robin Walker MP, Minister of State, Northern Ireland Office on the measures being taken by the Northern Ireland Office to prepare for the implementation of the Protocol on Ireland/Northern Ireland.
  • Northern Ireland Office engagement with other Government departments, the Northern Ireland Executive, the political parties of Northern Ireland, and the Irish Government in relation to the Protocol
    The Northern Ireland Office's responsibility for engagement with Northern Ireland businesses, and how their concerns over implementation of the Protocol are being addressed

EU Committee criticises lack of engagement by Northern Ireland Office

Retrieved on: 
Thursday, July 9, 2020

The Lords EU Committee has written to Rt Hon Brandon Lewis MP, Secretary of State for Northern Ireland, expressing disappointment at the lack of engagement from his department in support of the Committee's scrutiny of the Protocol on Ireland/Northern Ireland.

Key Points: 
  • The Lords EU Committee has written to Rt Hon Brandon Lewis MP, Secretary of State for Northern Ireland, expressing disappointment at the lack of engagement from his department in support of the Committee's scrutiny of the Protocol on Ireland/Northern Ireland.
  • The Committee first requested an evidence session with the Secretary of State for Northern Ireland on 21 February 2020.
  • The Committee took evidence from Mr Gove in May, and he told the Committee that responsibility for engagement with the business community in Northern Ireland lay with the Secretary of State for Northern Ireland.
  • In its latest letter, the Committee repeats its request to hear oral evidence from the Northern Ireland Office before the recess, specifically to discuss the Department's engagement with businesses in Northern Ireland.

EU Committee criticises lack of engagement by Northern Ireland Office

Retrieved on: 
Thursday, July 9, 2020

The Lords EU Committee has written to Rt Hon Brandon Lewis MP, Secretary of State for Northern Ireland, expressing disappointment at the lack of engagement from his department in support of the Committee's scrutiny of the Protocol on Ireland/Northern Ireland.

Key Points: 
  • The Lords EU Committee has written to Rt Hon Brandon Lewis MP, Secretary of State for Northern Ireland, expressing disappointment at the lack of engagement from his department in support of the Committee's scrutiny of the Protocol on Ireland/Northern Ireland.
  • The Committee first requested an evidence session with the Secretary of State for Northern Ireland on 21 February 2020.
  • The Committee took evidence from Mr Gove in May, and he told the Committee that responsibility for engagement with the business community in Northern Ireland lay with the Secretary of State for Northern Ireland.
  • In its latest letter, the Committee repeats its request to hear oral evidence from the Northern Ireland Office before the recess, specifically to discuss the Department's engagement with businesses in Northern Ireland.

Development of vaccines and treatments in managing the COVID-19 pandemic examined

Retrieved on: 
Friday, June 26, 2020

Professor Jonathan Van-Tam, Deputy Chief Medical Officer and Lead, Therapeutics Taskforce, Department of Health and Social Care

Key Points: 

Professor Jonathan Van-Tam, Deputy Chief Medical Officer and Lead, Therapeutics Taskforce, Department of Health and Social Care

Secretary of State questioned on Covid-19 (Coronavirus)

Retrieved on: 
Wednesday, May 13, 2020

Rt Hon Brandon Lewis MP, Secretary of State for Northern Ireland

Key Points: 

Rt Hon Brandon Lewis MP, Secretary of State for Northern Ireland
Likely topics for discussion include:
how the Northern Ireland Office has responded to the pandemic;
strategies for exiting the lockdown;
financial support for individuals and businesses; and
the economic effect of Covid-19.